21199 ⎘
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant; Organic adjuvants Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
Dried saponin liposomal composition
#302UspA2 protein constructs and uses thereof
#303Treatment of infection
#304Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
#305Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvant
#306Lipidated immune response modifier compound compositions, formulations, and methods
#307Genetically engineered Foot and Mouth Disease Virus and related proteins, polynucleotides, compositions, methods and systems
#308NOVEL ADJUVANT FORMULATIONS
#309COMBINATION VACCINES WITH SEROGROUP B MENINGOCOCCUS AND D/T/P
#310NEW ADJUVANT AND VACCINE COMPOSITION CONTAINING THE SAME
#311Hepatitis C virus E1/E2 heterodimers and methods of producing same
#312Methods and compositions for liposomal formulation of antigens and uses thereof
#313Polymer conjugate vaccines
#314Immunogenic compositions against
#315Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
#316Methods of using a vaccine composition containing synthetic adjuvant
#317Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#318Vaccine composition containing synthetic adjuvant
#319Lipidated immune response modifier compound compositions, formulations, and methods
#320LIPID VESICLE COMPOSITIONS AND METHODS OF USE
#321Parenteral norovirus vaccine formulations
#322Adjuvanted formulations of booster vaccines
#323Vaccine Composition Containing Synthetic Adjuvant
#324Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof
#325Allergy vaccine composition
#326Immunostimulatory compositions, particles, and uses related thereto
#327Thermostable Vaccine Compositions and Methods of Preparing Same
#328Vaccine formulation, preparation method therefor and use thereof
#329antigenic composition
#330Display platform from bacterial spore coat proteins
#331Synthetic glucopyranosyl lipid adjuvants
#332Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#333ADJUVANT COMPOSITIONS COMPRISING A NON-IONIC ISOTONICITY AGENT
#334Lipid A mimics, methods of preparation, and uses thereof
#335Methods and compositions for induction of immune response
#336VACCINATION
#337DISACCHARIDE SYNTHETIC LIPID COMPOUNDS AND USES THEREOF
#338Antibodies With Simultaneous Subsite Specificities To Protein and Lipid Epitopes
#339Immunogenic composition
#340LIPIDATED IMMUNE RESPONSE MODIFIER COMPOUND COMPOSITIONS, FORMULATIONS, AND METHODS
#341Multivalent stable vaccine composition and methods of making same
#342Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#343MODULATION OF NKT CELL ACTIVITY WITH ANTIGEN-LOADED CD1d MOLECULES
#344Micellar polypeptide vaccine having pegylated phospholipids as carrier
#345Adjuvant compositions
#346SYNERGISTIC COMPOSITIONS OF IMMUNOSTIMULATING RECONSTITUTED INFLUENZA VIROSOMES WITH IMMUNOPOTENTIATORS AND VACCINES CONTAINING THEM
#347Vaccines for HSV-2
#348Compositions including beta-glucans and method of use
#349Lipid vesicle compositions and methods of use
#350Cancer immune-based therapy
#351Modified lipopolysaccharide glycoform and method of use
#352Vaccine adjuvant compositions
#353Vaccine pharmaceutical composition for transdermal administration
#354Adjuvants
#355Method for preventing or treating infection
#356Method and compositions
#357Glycoconjugate vaccines
#358PRIME-BOOST REGIMENS WITH A TLR4 AGONIST ADJUVANT AND A LENTIVIRAL VECTOR
#359Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby
#360Synthetic glucopyranosyl lipid adjuvants
#361Non-toxic adjuvant formulation comprising a monophosphoryl lipid A (MPLA)-containing liposome composition and a saponin
#362Treatment of infection
#363Immunogenic compositions for the prevention and treatment of meningococcal disease
#364METHODS FOR ENHANCING THE IMMUNOSTIMULATION POTENCY OF ALUMINUM SALT-ABSORBED VACCINES
#365Nanoparticles for immune stimulation
#366Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#367Sulfated-glycolipids as adjuvants for vaccines
#368Methods and compositions for liposomal formulation of antigens and uses thereof
#369Mucosal adjuvants and delivery systems
#370Methods for inducing an immune response
#371Polyvalent influenza virus-like particles (VLPS) and use as vaccines
#372Synthetic derivatives of MPL and uses thereof
#373Methods for inducing an immune response
#374MENINGOCOCCAL MULTIVALENT NATIVE OUTER MEMBRANE VESICLE VACCINE, METHODS OF MAKING AND USE THEREOF
#375Swarm immunization with envelopes from CH505
#376Combinatorial platform for the display of surface adjuvants and antigens
#377Method for Inducing a TRIF-Bias
#378Xenoantigen-displaying anti-cancer vaccines and method of making
#379Vaccine compositions comprising a saponin adjuvant
#380Compositions and methods
#381Vaccine delivery systems using yeast cell wall particles
#382Lipid vesicle compositions and methods of use
#383Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent
#384LIPOTEICHOIC ACID FROM LACTOBACILLI AS A POTENT IMMUNE STIMULATORY ADJUVANT FOR VACCINE DEVELOPMENT
#385Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#386ANTI-TUMOR COMPOSITIONS AND USES THEREOF
#387MPER-liposome conjugates and uses thereof
#388Vaccine compositions
#389UspA2 protein constructs and uses thereof
#390Multivalent stable vaccine composition and methods of making same
#391Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity
#392Lipid nanoparticle vaccine adjuvants and antigen delivery systems
#393Modified glycolipids and methods of making and using the same
#394Peptide particle formulation
#395Single vial vaccine formulations
#396Immunomodulatory compositions and methods of use thereof
#397Glucopyranosyl Lipid A and Allergen Formulations For Sublingual Administration
#398Lipid vesicle compositions and methods of use
#399Injectable vaccine composition
#400Adjuvant composition, vaccine composition containing the same, and method for producing both of them
#401Adjuvanted formulations of booster vaccines
#402Vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific T-cell responses
#403Nasal mucosal vaccine composition
#404Mucosal vaccine composition
#405Glycan conjugates and methods of use thereof
#406Compound and method for vaccination and immunisation
#407Papillomavirus-like particles (VLP) as broad spectrum human papillomavirus (HPV) vaccines
#4081,2,3-triazole-tethered carbohydrate-di and tri lipidated cysteine conjugates useful as vaccine adjuvants and process for preparation thereof
#409Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#410Mucosal vaccine composition
#411Vaccine Compositions for Drug Addiction
#412Vaccine
#413IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA
#414Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof
#415Compositions and methods
#416Lipidated immune response modifier compound compositions, formulations, and methods
#417Vaccine Composition
#418Antibody-mediated anti-tumor activity induced by Reishi mushroom polysaccharides
#419Vaccine Composition And Method Of Use
#420Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
#421AN ISOLATED IMMUNOGENIC BACTERIAL ANTIGEN AND ITS USE IN THE PREVENTION AND TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA
#422Disaccharide synthetic lipid compounds and uses thereof
#423Sphingoglycolipid analogues
#424Immunostimulatory combinations
#425RECOMBINANT RSV ANTIGENS
#426IMMUNOGENIC COMPOSITION COMPRISING NEISSERIA MENINGITIDIS MACROPHAGE INFECTIVITY POTENTIATOR PROTEIN AND METHODS FOR USING THEM
#427Vaccine to prevent mycoplasmal infections in waterfowl
#428MUCINOUS GLYCOPROTEIN (MUC-1) VACCINE
#429HERPES VIRUS VACCINES AND TREATMENTS
#430METHOD OF TREATING LUNG CANCER BY VACCINATION WITH MUC-1 LIPOPEPTIDE
#431VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT
#432IMMUNOTHERAPY OF CANCER THROUGH COMBINATION OF LOCAL AND SYSTEMIC IMMUNE STIMULATION
#433Lipid vesicle compositions and methods of use
#434Immunogenic composition in emulsion form
#435Prevention and treatment of mycobacterium infection
#436Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity
#437Norovirus vaccine formulations
#438Nanoparticle-based compositions
#439METHOD FOR TREATING A beta-AMYLOIDOSIS
#440Immunotherapeutic potential of modified lipooligosaccharides/lipid A
#441Parenteral norovirus vaccine formulations
#442Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists
#443Immunologically active compositions
#444Method of Treating Patients with a Mucinous Glycoprotein (MUC-1) Vaccine
#445Conjugate compounds
#446Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
#447Vaccine composition containing synthetic adjuvant
#448Immunogenic Composition and Methods of Using the Compositions for Inducing Humoral and Cellular Immune Responses
#449Immunogenic compositions for the prevention and treatment of meningococcal disease
#450Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#451Glycoconjugate vaccines
#452Modified lipopolysaccharide glycoform and method of use
#453Immunogenic composition
#454METHOD FOR TREATING A SYNUCLEIOPATHY
#455Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase
#456COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF MALIGNANT GLIOMAS
#457Lipid vesicle compositions and methods of use
#458Compositions and methods for vaccination
#459Antibodies with simultaneous subsite specificities to protein and lipid epitopes
#460Carbohydrate-glycolipid conjugate vaccines
#461Anti-HER2 vaccine based upon AAV derived multimeric structures
#462Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#463Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#464Veterinary vaccine
#465Nanoparticles for treatment of allergy
#466Oil-based adjuvants
#467ADJUVANTED FORMULATIONS OF PEDIATRIC ANTIGENS
#468Disaccharide synthetic lipid compounds and uses thereof
#469METHOD OF VACCINATION AGAINST HUMAN PAPILLOMAVIRUS
#470COMPOSITIONS OF VACCINES AND ADJUVANTS AND METHODS FOR THE TREATMENT OF URINARY TRACT INFECTIONS
#471Rational vaccine design for hepatitis C virus
#472Vaccine
#473Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
#474IMMUNOSTIMULATORY COMPOSITIONS, PARTICLES, AND USES RELATED THERETO
#475MUC1 Based Glycolipopeptide Vaccine with Adjuvant
#476Nanocarriers with multi-photon response elements
#477ANTI-TUMOR COMPOSITIONS AND USES THEREOF
#478Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
#479Adjuvant formulations comprising TLR4 agonists and methods of using the same
#480Compositions and methods for vaccinating against HSV-2
#481CHLAMYDIA ANTIGEN COMPOSITIONS AND USES THEREOF
#482Tuberculosis compositions and methods of using the same
#483Compositions and methods for vaccinating against HSV-2
#484Compositions and methods for treating influenza
#485Adjuvanted influenza virus compositions
#486Compositions and vaccines comprising vesicles and methods of using the same
#487Monophosphorylated lipid A derivatives
#488Methods of using a vaccine composition containing synthetic adjuvant
#489Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
#490Modified pathogens for use as vaccines
#491Synthetic glucopyranosyl lipid adjuvants
#492Compositions including β-glucans and methods of use
#493Compositions and methods
#494Methods and compositions for liposomal formulation of antigens and uses thereof
#495Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors
#496COMPOSITIONS AND USES
#497Norovirus vaccine formulations
#498Methods for the production of 3-O-deactivated-4′-monophosphoryl lipid A (3D-MLA)
#499Inactivating pathogens with oxidizing agents for vaccine production
#500Compositions and methods for activating innate and allergic immunity
#501Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant
#502Treatment of streptococcal infections
#503Herpes virus vaccine and methods of use
#504Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
#505Vaccines for HSV-2
#506Process for preparing vaccine composition
#507Vaccine
#508Vaccines for HSV-2
#509Adjuvant compositions
#510Vaccine composition containing synthetic adjuvant
#511Peptide and conjugate vaccines for fungal infections
#512antigenic composition
#513Disaccharide synthetic lipid compounds and uses thereof
#514Norovirus vaccine formulations
#515Method of conferring a protective immune response to Norovirus
#516Norovirus vaccine formulations
#517Parenteral norovirus vaccine formulations
#518Vaccine for inducing an improved immune reaction
#519Vaccines against
#520Vaccine composition
#521Adjuvanted formulations of booster vaccines
#522Lipidated immune response modifier compound compositions, formulations, and methods
#523Method for preparing liposome-based constructs
#524Methods for detecting antibody that specifically bind a siderophore receptor polypeptide
#525Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity
#526Immunogenic compositions and methods for treating neoplasia
#527Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
#528Subunit vaccines for herpes viruses and methods of use
#529Immunotherapy comprising TLR9 ligand and CD40 ligand
#530Compositions and methods for treating influenza
#531Vaccine composition containing synthetic adjuvant
#532Chimeric vaccine for -induced disease
#533Methods of using a vaccine composition containing synthetic adjuvant
#534Prevention And Treatment Of Amyloidogenic Disease
#535Targeted heterologous antigen presentation on calicivirus virus-like particles
#536Codon-optimized polynucleotide-based vaccines against human infection
#537Inactivating pathogens with oxidizing agents for vaccine production
#538TREATMENT OF STREPTOCOCCAL INFECTIONS
#539Compositions and methods for vaccinating against HSV-2
#540Compositions and methods for vaccinating against HSV-2
#541Compositions and methods for vaccinating against HSV-2
#542Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
#543Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease
#544Immunogenic compositions for the prevention and treatment of meningococcal disease
#545COMPOSITIONS AND METHODS FOR WT1 SPECIFIC IMMUNOTHERAPY
#546Immunogenic compositions for the prevention and treatment of meningococcal disease
#547VACCINE AGAINST NEOPLASTIC OR CANCEROUS LESIONS CAUSED BY HUMAN PAPILLOMA VIRUS (HPV), PROCEDURES, USES AND METHODS
#548SYNTHETIC LONG PEPTIDE (SLP)-BASED VACCINES
#549MUC1 based glycolipopeptide vaccine with adjuvant
#550Compositions and methods for activating innate and allergic immunity
#551Prevention and Treatment of Amyloidogenic Disease
#552Vaccine for Modulating Between T1 and T2 Immune Responses
#553Vaccine for modulating between T1 and T2 immune responses
#554STABLE IMMUNOGENIC PROTEIN HAVING MULTIPLE CYSTEINES MOLECULES PROCESS THEREFOR AND COMPOSITION THEREOF
#555Process for the production of immunogenic compositions
#556Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines
#557Nanocarriers with multi-photon response elements
#558MUC1 based glycolipopeptide vaccine with adjuvant
#559Immunogenic compositions for the prevention and treatment of meningococcal disease
#560Peptide, adjuvants, vaccines, and methods of use
#561Immunizing Compositions and Methods of Use
#562Immunizing compositions and methods of use
#563Lipid vesicle compositions and methods of use
#564RSV F PROTEIN COMPOSITIONS AMD METHODS FOR MAKING SAME
#565Norovirus vaccine formulations
#566Oral Vaccines for Producing Mucosal Immunity
#567Methods for the induction of broadly anti-HIV-1 neutralizing antibody responses employing liposome-MPER peptide compositions
#568Enhancement of Pathogen-Specific Memory Th17 Cell Responses
#569Lipopolysaccharide of ochrobactrum intermedium and their use as immunostimulant of mammalians
#570Vaccine for cervical cancer
#571IMMUNOGENIC COMPOSITIONS HAVING LOW SODIUM CHLORIDE CONCENTRATION
#572NOROVIRUS VACCINE FORMULATIONS
#573Recombinant RSV vaccines
#574Papillomavirus-like particles (VLP) as broad spectrum human papillomavirus (HPV) vaccines
#575ADJUVANT COMPOSITIONS COMPRISING A NON-IONIC ISOTONICITY AGENT
#576NOVEL COMPOSITIONS
#577Compositions and Methods for Modulating a Cytotoxic T Lymphocyte Immune Response
#578CASB7439 constructs
#579METHOD OF INDUCING NEUTRALIZING ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS
#580NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS
#581NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS
#582TREATMENT OF INFECTION
#583Treatment of allergic conditions using a composition containing synthetic adjuvant
#584Methods for one-dose intradermal delivery for non-live trivalent influenza vaccine
#585NOVEL IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE
#586KITS FOR ONE-DOSE INTRADERMAL DELIVERY FOR NON-LIVE TRIVALENT INFLUENZA VACCINE
#587NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS
#588Immunological herpes simplex virus antigens and methods for use thereof
#589Malaria prime/boost vaccines
#590MODULATION OF THE IMMUNE RESPONSE
#591Inactivated dengue virus vaccine with aluminium-free adjuvant
#592Prevention and Treatment of Amyloidogenic Disease
#593RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
#594Peptide particle formulation
#595Vaccines against chlamydial infection
#596HIV-1 Immunogenic Compositions
#597MULTIVALENT ADJUVANTED INFLUENZA VIRUS COMPOSITIONS
#598PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#599IMMUNOSTIMULATORY COMBINATIONS
#600METHOD OF INDUCING AN ANTI-VIRAL IMMUNE RESPONSE